Technology

Wedbush Securities managing director analyzes the technology sector and reveals if the bear market is over on 'Varney & Co.'

Rep. Roger Williams, R-Texas, discusses the impact of Sens. Manchin and Schumer's deal on small businesses, the semiconductor bill and the Republicans' response to Democrats' spending.

Rep. Carlos Gimenez, R-Fla., discusses a new study that claims Americans earning under $400K would see tax increases, the semiconductor bill moving through the Senate and the Biden administration approving border wall construction in Yuma, Arizona.

Barron’s markets editor Ben Levisohn, Barron’s reporter Carleton English and Barron’s senior writer Al Root discuss trends in markets, big tech and renewable energy after second quarter GDP signals recession.

Constellation Research CEO R 'Ray' Wang provides expert analysis of the Big Tech rally and how it is impacting the ‘market tune’ on ‘Varney & Co.’ 

Wedbush Securities managing director Daniel Ives analyzes the tech industry following a negative second quarter and the economy formally entering a recession.

Evercore ISI senior managing director Mark Mahaney provides his projections for some Big Tech stocks on 'Varney & Co.'

SlateStone Wealth chief market strategist Kenny Polcari reveals where he sees value in technology stocks on 'Varney & Co.'

Cristiano Amon discusses what the $52 billion chips package means for his business and if the bill will resolve supply chain disruptions on 'The Claman Countdown.'

Cristiano Amon discusses what the $52 billion chips package means for his business and if the bill will resolve supply chain disruptions on 'The Claman Countdown.'

Fox News medical contributor and Johns Hopkins School of Medicine professor Dr. Marty Makary reacts to diversity and equity curriculum reportedly being taught to medical students.

While Hologic CEO Stephen MacMillan ‘welcomes’ the idea of expanding domestic microchip production, he warns the $280 billion chips bill won’t have an impact for years.

Hologic CEO Stephen MacMillan says the health testing business has seen the most growth in surgical and women’s health needs over the last quarter.

Rep. Michael Burgess, R-Texas, says it was 'almost impossible' to support the CHIPS Act when Nancy Pelosi's husband bought more than $1 million in Nvidia weeks before a congressional vote that would provide massive subsidies to the industry. 

Rep. Mike Gallagher, R-Wis., weighs in on President Biden’s phone call with Xi Jinping ahead of House Speaker Nancy Pelosi’s visit to Taiwan on ‘Mornings with Maria.’